Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium in Coronaries
NCT00000610Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Apr 1998
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in ST elevation myocardial infarction (STEMI) comparing Magnesium Sulfate with Placebo (2 arms). Primary endpoint: 30-day all-cause mortality. Started Apr 1998; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00000610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000610.